Risk for Severe COVID-19 Low With Congenital Heart Disease
MONDAY, Oct. 19, 2020 -- Most patients with congenital heart disease (CHD) are not at risk for severe COVID-19 infection, according to a study published online Oct. 14 in the Journal of the American Heart Association.
Matthew J. Lewis, M.D., from the Columbia University Irving Medical Center in New York City, and colleagues assessed the impact and predictors of COVID-19 infection and severity among 53 patients with CHD diagnosed with COVID-19 between March 1 and July 1, 2020.
The researchers found that 10 CHD patients were younger than 18 years old (median age, 34 years). More than half (58 percent) had complex congenital anatomy, including 10 with a Fontan repair. Additionally, eight patients had a genetic syndrome, six had pulmonary hypertension, and nine were obese. Eighteen adults were physiologic class C or D. Among all 53 patients, nine had a moderate or severe infection, including three who died. The presence of a genetic syndrome (odds ratio, 35.82) and physiological Stage C or D in adults (odds ratio, 19.38) were significantly associated with moderate or severe infection.
"While our sample size is small, these results imply that specific congenital heart lesions may not be sufficient cause alone for severe COVID-19 infection," the authors write.
© 2021 HealthDay. All rights reserved.
Posted: October 2020
Further Support and Information on COVID-19
Read this next
Here is what the editors at Physician's Briefing chose as the most important COVID-19 developments for you and your practice for the week of Jan. 19 to 22, 2021. This roundup...
FRIDAY, Jan. 22, 2021 -- Two-thirds of Americans are concerned about going to medical appointments even for an emergency when COVID-19 rates are high in their area, according to...
FRIDAY, Jan. 22, 2021 -- An antibody drug that has emergency use authorization from the U.S. Food and Drug Administration for use in early-stage COVID-19 patients with symptoms...
More News Resources
- FDA Medwatch Drug Alerts
- Daily MedNews
- News for Health Professionals
- New Drug Approvals
- New Drug Applications
- Drug Shortages
- Clinical Trial Results
- Generic Drug Approvals
Subscribe to our Newsletter
Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.